LIFE

SCIENCES

LIFE SCIENCES

COMMERCIAL STRATEGY · FUNDING · PARTNERSHIPS

Making Science Investable

Making Science Investable

We help life sciences companies build a stronger business case—and bring the right investors, partners and buyers around the table.

You see the potential.

Let’s help others see it too.

Personally with Coert and Karin. The Netherlands & Malaysia.

Personally with Coert and Karin. The Netherlands & Malaysia.

Karin & Coert. Personally involved.

From Molecule to Market.

35+

years in pharma,

consumer health & strategy

100+

product & market

introductions guided

25

countries under commercial

strategy responsibility

Europe ↔ Asia

International experience.

Local understanding.

WHAT IS YOUR NEXT MOVE?

What would help your business

move forward?

You know the next step.

Let’s get you ready for it.

Whether you want to grow, attract funding or find a partner, we help you work out the best route—and take it forward.

Growth, investment or a strategic partner: each needs a clear commercial direction, a credible case and the right people involved.

Grow the business.

We help you decide which customers and markets to focus on, why they would choose your innovation and how your team can turn that opportunity into business.

Get ready for investors.

We help you build a clear business case, with realistic financials and a convincing explanation of what the investment will make possible.

Find the right partner or buyer.

We help you identify suitable partners or buyers, explain why your innovation matters to them and bring the right people into the conversation.

Biotech · Medtech · Diagnostics · Pharma · Consumer health

Biotech · Medtech · Diagnostics · Pharma · Consumer health

HOW WE HELP

Position. Package. Partner.

We build on what you already have, strengthen what is missing and agree which conversations make sense now. Preparation and relevant market feedback can move together.

We build on what you already have, strengthen what is missing and agree which conversations make sense now. Preparation and relevant market feedback can move together.

01 · POSITION

Know where
you can win.

Define the commercial potential of your innovation. Clarify market opportunity, differentiation, risks, and value logic.

A clear direction and a practical plan.

What this can include

Commercial strategy, positioning, business model, market-entry choices and financial assumptions. For growth assignments: priority opportunities, team roles, a 90-day action plan and a 12-month roadmap.

02 · PACKAGE

Build a case

people can back.

Develop clear materials that support investment or M&A discussions. Teasers, presentations, structured information documents.

A credible case. Materials ready to use.

What this can include

Business plan, financial model, valuation rationale, investor deck, teaser and partner or customer presentations. Data-room priorities, Q&A and preparation for important conversations.

03 · PARTNER

Get the right people

around the table.

Identify and approach the right strategic or industry partners. Guide discussions toward alignment and opportunity.

Focused outreach and active follow-through.

What this can include

Candidate selection, target mapping, tailored approaches, selected introductions, meeting preparation and follow-up. Transaction and due-diligence support within an agreed scope, alongside specialists where needed.

What this can include

Commercial strategy, positioning, business model, market-entry choices and financial assumptions. For growth assignments: priority opportunities, team roles, a 90-day action plan and a 12-month roadmap.

What this can include

Business plan, financial model, valuation rationale, investor deck, teaser and partner or customer presentations. Data-room priorities, Q&A and preparation for important conversations.

What this can include

Candidate selection, target mapping, tailored approaches, selected introductions, meeting preparation and follow-up. Transaction and due-diligence support within an agreed scope, alongside specialists where needed.

When needed, we collaborate with trusted transaction and legal specialists to support formal deal execution.

A focused project or ongoing senior support. We agree the scope, priorities and deliverables before we start.

OUR TRACK RECORD

Experience on both

sides of the table.

We have led pharma and consumer-health businesses and helped life sciences founders prepare for investment, partnerships and sale.

Medtech · Pharma · Diagnostics · Consumer health · Biotech

This is a Paragraph Font

Companies &
brands sold

Specialty pharma and consumer-health brands. Identified potential buyers, supported negotiations and helped bring transactions to completion.

Commercial agreements

completed

Pharmaceutical licensing, production and distribution partnerships across Europe and Asia.

Investors &

partners engaged

GI biotech, antibiotic alternatives, preclinical biotech and advanced therapies. Investor positioning, introductions and strategic discussions.

EXAMPLES OF AREAS WE HAVE WORKED IN

Gastrointestinal medicines

Antibiotic alternatives

Eye laser technology

GI biotech

Antibiotic alternatives

Preclinical biotech

Nasal drug delivery

Liver cell technology

Oncolytic immunotherapy

Consumer health

Diagnostic imaging

CBD & cannabinoid products

Selected experience from senior executive roles and Senz advisory assignments.

Transaction sizes ranging from multi-million euro licensing deals to full company exits.

WHY SENZ

We know what it takes to turn science into business.

We know what it takes to turn science into business.

We have led international healthcare businesses ourselves. Today, we bring that experience to founders and management teams turning promising innovations into commercially successful companies.

We've led international healthcare businesses ourselves. Today, we bring that experience to founders and management teams turning promising innovations into commercially successful companies.

Industry understanding.

A physician with an MBA. A pharmacist with global commercial leadership experience. We connect the science, the market and the numbers.

Direct senior involvement.

You work with Coert and Karin on the choices, the numbers and the conversations. Personally involved from start to finish.

Europe and Asia, connected.

Based in the Netherlands and Malaysia, with international industry relationships and experience across markets.

Drs. Karin van Zuilen

Pharmacist · Former Global Marketing Director · Strategy & Commercialisation

Pharmacist · Former Global Marketing Director · Strategy & Commercialisation

35+ years in international pharma, consumer health and business strategy. Former Global Marketing Director at Astellas/Yamanouchi, leading commercial strategy across 25 countries and more than 100 product and market launches.

Helped achieve No. 1 market positions for five brands.

Today, Karin helps life sciences companies turn promising innovations into clear market opportunities, strong commercial strategies and businesses ready for growth.

Coert Huijbregsen, MD, MBA

MD · MBA · Former Pharma Managing Director · Commercialisation, Investment & M&A

MD · MBA · Former Pharma Managing Director · Commercialization, Investment & M&A

35+ years in pharmaceutical leadership and life sciences advisory. Former Managing Director of Viatris, with full P&L responsibility for a €30M+ business and 50 employees.

Combines medical expertise with hands-on commercial and general management experience.

Today, Coert helps life sciences companies build credible business plans, financial models and valuations, and prepare for investment, strategic partnerships and M&A.

IN OUR CLIENTS' WORDS

A stronger business case.

A real step forward.

A stronger business case.

A real step forward.

We have led pharma businesses and supported life sciences founders. We help you prepare the strategy, numbers and story that investors and industry partners will challenge.

We have led pharma businesses and supported life sciences founders. We help you prepare the strategy, numbers and story that investors and industry partners will challenge.

Stronger investment cases that brought relevant parties to the table.

“Over several years, Senz Life Sciences was our preferred strategic advisory partner for international life sciences projects. They helped companies strengthen their strategy, business case and investment readiness, and consistently brought high-quality investors and strategic partners to the table.”

Dato Guna Mahalingam

Managing Partner · Strategic Swiss Partners · Switzerland

Stronger investment cases.

Relevant parties at the table.

“Their advice was always objective, commercially grounded and focused on long-term value creation. […] Across numerous engagements, Senz consistently succeeded in bringing high-quality strategic and financial parties to the table, creating competitive processes and materially improving transaction readiness.”

Dato Guna Mahalingam

Managing Partner · Strategic Swiss Partners

From strong science to a strategy and numbers we can defend.

“Coert and Karin helped us set a clear strategy, build realistic financial scenarios and develop a valuation we can confidently defend with investors and partners. Working with them felt like having two experienced business partners at the table, rather than external consultants.”

Elena Sgaravatti

Founder & General Manager · PlantaRei Biotech · Italy

From complex science

to investor conversations.

“Our message wasn’t landing. It was too complex for the investor audience. […] They opened doors, pitched on our behalf, and kept momentum when it mattered most. […] Thanks to Senz, we are not just seen, we are understood.”

Sara Isbell

Co-Founder & CEO · Enabled Therapeutics

From complex science

to investor conversations.

“Our science was groundbreaking, but our message was too complex for investors. Karin and Coert helped us tell a clear, compelling story without losing the science. They opened doors, pitched on our behalf and kept momentum when it mattered most. Thanks to Senz, we are not just seen, we are understood.”

Sara Isbell

Co-Founder & CEO · Enabled Therapeutics · USA

Financial insight that helps us make informed decisions.

“Coert's ability to prepare detailed and accurate financial documents is exceptional, providing a solid foundation for strategic planning and investor relations. His combination of medical expertise, business acumen and communication skills makes him an invaluable asset.”

Hans U. Baer, MD

CEO Bauchmedizin AG / Baermed · Switzerland

A strategic sounding board who
understands our business.

“Karin has been a valuable strategic sounding board over several years. She helps us see the bigger picture, connect the different pieces and make clearer business decisions. Her experience in developing new products and business concepts, combined with her independent advice, has been invaluable.”

Sophian Abdul Rahman

CEO · Delightex / Mudo Labs · Singapore

A PRACTICAL FIRST STEP

Where do

we begin?

Where do

we begin?

Tell us where you are, what you want to achieve and what is getting in the way. We will explore where we can make a difference.

Tell us where you are, what you want to achieve and what is getting in the way. We will explore where we can make a difference.

We work with a limited number of companies each year.

If we engage, we commit fully.

We work with a limited number of companies each year.

If we engage, we commit fully.

Can we work with you on just one part?

Yes. You may need help with your strategy, your investment materials or finding suitable partners. We start with what you need and build on the work you’ve already done. You don’t have to go through the full Position, Package, Partner approach.

Can you work as part of our team?

Yes. We offer defined projects and ongoing fractional CMO/CCO support. You gain senior commercial capacity with clear responsibilities, priorities and agreed deliverables.

Can we begin with an independent review?

Yes. Our Investment Readiness Roadmap reviews your strategy, positioning, financials and materials. You receive an assessment, a personal walkthrough and a 90-day action roadmap. Scope and fee are agreed before we start.

Can you find investors or strategic partners?

We research suitable parties, make selected approaches and introductions, and prepare and follow up conversations. We assess what is ready now and what needs strengthening. Funding and agreements depend on third-party decisions and are not guaranteed.

Do you support portfolio companies?

Yes. We work with family offices, investors and innovation programmes to help their companies strengthen commercial direction, business cases and readiness for customers, investment or partnerships.

YOUR NEXT STEP

Your innovation can

make a difference.
Let’s make it happen.

Your innovation can make a difference.
Let’s make it happen.

Let’s talk about your company, where you want to go

and what would help you take the next step.

Let’s talk about your company, where you want to go

and what would help you take the next step.

A confidential first conversation with Coert and Karin. No obligation.

To ensure alignment, we ask you to complete a short qualification form.

If there is a strong fit, we will schedule a private discussion.

A confidential first conversation with Coert and Karin. No obligation.

To ensure alignment, we ask you to complete a short qualification form.

If there is a strong fit, we will schedule a private discussion.

Senz Life Sciences
A business unit of Senz Strategy Consulting.

Senz Life Sciences
A business unit of Senz Strategy Consulting.

LET'S CONNECT

[email protected] ↗
WhatsApp Karin ↗

The Netherlands · Malaysia

© 2026 Senz Strategy Consulting · 201801013232 (1275248-H)

© 2026 Senz Strategy Consulting
201801013232 (1275248-H)